We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Patient Safety Improved with Reduction in Blood Transfusions

By HospiMedica International staff writers
Posted on 28 Oct 2010
Blood transfusions save lives, but they also carry risks. More...
Studies during the past 10 years have found that transfusions make patients more susceptible to infections and increase the risks of poor outcomes such as longer hospital stays, cancer recurrences, and multi-organ system failures.

Transfusions of red blood cells, platelets, plasma, and other blood products were approved decades ago without randomized controlled clinical trials to establish optimal uses. Consequently, doctors sometimes order more transfusions than necessary said Phillip J. DeChristopher, M.D., Ph.D., professor in the Department of Pathology at Loyola University Chicago Stritch School of Medicine and medical director of transfusion medicine, blood bank, and apheresis.
He noted that the amount of plasma transfused per patient in the United States is two to three times higher than the amounts transfused in Canada and Europe.

In a Loyola University study, a new initiative was launched for blood utilization as part of its Blood Management Program. The program implemented blood-use protocols that included evidence-based indications, educational programs for doctors and nurses, and oversight of the Blood Utilization Review Committee.

The study demonstrated how the hospital improved patient safety and cut costs by reducing the number of blood transfusions. These results were reported at the recent annual meeting of the College of American Pathologists, which took place from September 26–29, 2010, in Chicago (IL, USA).

Results of a small clinical trial reported at the American Society of Anesthesiologists annual meeting in San Diego (CA, USA) on October 18, 2010, demonstrated how a new noninvasive continuous blood monitor could reduce the number of blood transfusions given during surgery.

Developed by Masimo (Irvine, CA, USA) the Radical-7 pulse oximeter equipped with continuous hemoglobin monitoring sensors helped anesthesiologists to know whether a patient's blood count is critical without having to wait for lab reports. The results of the trial showed that the real-time blood-monitoring tool could cut the number of transfusions by almost 86%.

Making sure blood transfusions are performed only when necessary would help lower complications from transfusions. Although they save lives, transfusions also carry risks of serious immune reactions. Blood management will also help relieve chronic shortages in the blood supply, especially during summers and holiday seasons when donations drop.

Related Links:

Masimo





Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.